What question did this study set out to answer?

Determine whether calmodulin regulates the cardiac muscle calcium release channel (RyR2) by interacting with a conserved binding domain previously identified in the skeletal muscle isoform (RyR1).

June 1, 2003Journal of Biological ChemistryOpen Access

Molecular Basis of Calmodulin Binding to Cardiac Muscle Ca2+ Release Channel (Ryanodine Receptor)

View Full Paper

Ask AI

Bookmark

Population

Cardiac muscle Ca2+ release channel and skeletal muscle ryanodine receptor models

Comparison

Deletion and mutation of putative Calmodulin… vs Wild type (WT)-RyR2 and WT-RyR1

Design

Preclinical

Authors

NYNaohiro YamaguchiUniversity of Delhi LXLe XuChina West Normal University DPDaniel A. PasekUniversity of North Carolina at Chapel Hill

Discussion

Member takes

Implication

Defines conserved CaM site on RyR2; leaves open in vivo cardiac effects and therapeutic targeting.

Key Points

Determine whether calmodulin regulates the cardiac muscle calcium release channel (RyR2) by interacting with a conserved binding domain previously identified in the skeletal muscle isoform (RyR1).
Engineered deletion mutants (lacking residues 3583–3603) and specific point mutants in the putative calmodulin binding domain of RyR2, alongside corresponding mutations in RyR1.
Quantified direct protein interaction using [35S]calmodulin binding assays across calcium concentrations below and above 1 μM.
Assessed channel gating and functional inhibition in response to calmodulin using single-channel electrophysiological recordings.
Deletion of RyR2 residues 3583–3603 reduced [35S]calmodulin binding to background levels and abolished channel inhibition at both low (<1 μM) and high (>1 μM) calcium levels.
Individual and double point mutations (W3587A, L3591D, F3603A, W3587A/L3591D, L3591D/F3603A) significantly reduced or eliminated [35S]calmodulin binding and functional single-channel inhibition.
Substitutions targeting four divergent residues between RyR1 and RyR2 exhibited wild-type binding and regulation, whereas corresponding mutations in RyR1 produced functional responses distinct from RyR2.

Structured PICO

Population

Cardiac muscle Ca2+ release channel (Ryanodine Receptor, RyR2) and skeletal muscle ryanodine receptor (RyR1) models

Intervention

Deletion and mutation of putative Calmodulin (CaM) binding sites (e.g., RyR2 amino acid residues 3583-3603, W3587A, L3591D, F3603A)

Comparator

Wild type (WT)-RyR2 and WT-RyR1

Outcome

[35S]CaM binding levels and single channel activities (inhibition by CaM)surrogate

Calmodulin regulates both RyR1 and RyR2 by binding to a single, highly conserved binding site, with other type-specific sites likely responsible for differential functional regulation.

Cite This Study

Yamaguchi et al. (2003) studied this question.

synapsesocial.com/papers/6a8848c16304c7fd8e4dfcb3 https://doi.org/10.1074/jbc.m301125200

View Full Paper

Ask AI

Bookmark

Molecular Basis of Calmodulin Binding to Cardiac Muscle Ca2+ Release Channel (Ryanodine Receptor)

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Molecular Basis of Calmodulin Binding to Cardiac Muscle Ca2+ Release Channel (Ryanodine Receptor)

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider